Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.
Chevron projects 10%+ EPS growth, higher free cash flow, and strategic oil and gas expansion. The company targets 2–3% annual oil and gas production growth and $70 Brent breakeven.